An open-label, multicenter; Post-Marketing Requirement (

Project: Research project

Description

An open-label, multicenter; Post-Marketing Requirement (PMR) study to investigate the safety, tolerability and efficacy of octaplas in the management of pediatric patients who require replacement of multiple coagulation factors.
StatusFinished
Effective start/end date2/1/161/31/18

Funding

  • OCTAPHARMA USA, INC.

Fingerprint

Blood Coagulation Factors
Marketing
Pediatrics
Safety